Utama › Penyakit Hati Steatotik › New York › New York City
Kajian klinikal Penyakit Hati Steatotik di New York City, NY
16 kajian untuk Penyakit Hati Steatotik sedang mencari peserta di lokasi dalam dan sekitar New York City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Mengambil pesertaFasa 3
- 89bio Clinical Study Site, New York
- 89bio Clinical Study Site, New York
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Mengambil pesertaFasa 3
- 89bio Clinical Study Site, New York
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Mengambil pesertaFasa 3
- GSK Investigational Site, New York
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Mengambil pesertaFasa 2
- New York Presbyterian/Weill Cornell, New York
- Columbia University Iriving School of Medicine, New York
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Mengambil pesertaFasa 2
- Columbia University Irving Medical Center, New York
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Mengambil pesertaFasa 3
- NYU Langone Health, New York
- IMA Clinical Research Manhattan, New York
- New York Gastroenterology Associates, New York
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Mengambil pesertaFasa 3
- Akero Clinical Study Site, New York
- Akero Clinical Study Site, New York
- Akero Clinical Study Site, New York
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Mengambil pesertaFasa 3
- GSK Investigational Site, New York
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- Columbia University Irving Medical Center, New York
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Mengambil pesertaFasa 2
- GSK Investigational Site, New York
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Mengambil pesertaFasa 3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Mengambil pesertaFasa 2
- GSK Investigational Site, New York
Effect of Insulin Lowering on Lipogenesis
Mengambil pesertaFasa 1
- Columbia University Irving Medical Center, New York
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
Mengambil peserta
- Icahn School of Medicine at Mount Sinai, New York
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
Mengambil pesertaSukarelawan sihat dialu-alukan
- Weill Cornell Medicine, New York
High Fructose Diet, the Gut Microbiome, and Metabolic Health
Mengambil pesertaSukarelawan sihat dialu-alukan
- Mount Sinai Morningside, New York
Kajian Penyakit Hati Steatotik di bandar lain
- San Antonio, TX17 kajian
- Miami, FL16 kajian
- San Diego, CA14 kajian
- Austin, TX13 kajian
- Houston, TX13 kajian
- Richmond, VA12 kajian
- Tucson, AZ10 kajian
- Chandler, AZ10 kajian
- Hialeah, FL9 kajian
- Dallas, TX9 kajian
- Orlando, FL9 kajian
- St. Louis, MO9 kajian
Kajian lain di New York City
- Kanser Payudara136 kajian
- Kanser Paru-paru Bukan Sel Kecil121 kajian
- Kanser (semua jenis)109 kajian
- Kanser Prostat103 kajian
- Kanser Metastatik93 kajian
- Kanser Kolorektal78 kajian
- Kanser Ovari69 kajian
- Kanser Paru-paru60 kajian
- Mieloma Pelbagai60 kajian
- Kanser Pankreas60 kajian
- Kanser Endometrium52 kajian
- Leukemia Mieloid Akut51 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.